Growing Need for Pharmacogenetics Data for Pediatric Medications

Research By Sonya Tang Girdwood, MD, PhD, Laura Ramsey, PhD

Post Date: March 9, 2022 | Publish Date: March 9, 2022

→

Review article updates how growing children can differ from adults in how they metabolize drugs

An important review article in Pediatric Research led by Sonya Tang Girdwood, MD, PhD, and Laura Ramsey, PhD, at Cincinnati Children’s evaluates pediatric evidence for pharmacogenetic associations for drugs commonly prescribed by or encountered by pediatric clinicians across multiple subspecialties.

The article addresses proton pump inhibitors, selective serotonin reuptake inhibitors, ADHD medications, immunosuppressants and more.

The co-authors note that in many cases pediatric data are lacking regarding gene-drug interactions that can lead to adverse reactions. In other situations, the ways that neonates, infants, children and adolescents metabolize drugs can differ sharply from adults.

“The tremendous physiologic and metabolic changes that occur during childhood (and particularly in infancy and adolescence) provide the opportunity for the discovery of novel, pediatric-specific drug–gene interactions,” they write.

In addition to updating pediatric clinicians on recent pediatric pharmacogenetic evidence, the co-authors call for improving the quality of pediatric medication data so that pharmacogenetics can be better implemented into pediatric practice. Key factors include:

  • Adequate sample size
  • Clinically meaningful endpoints
  • Inclusion of participants representing those exposed to the drug with respect to age, indication, and ancestry
  • Robust assessment of the target gene

Read the article in Pediatrics Research

 

Publication Information

Original Title:Perspectives from the Society for Pediatric Research: pharmacogenetics for pediatricians
Published in:Pediatric Research
Publish date:March 9, 2022

Read the Article

Research By

  • Sonya Tang Girdwood, MD, PhD

    Division of Hospital Medicine, Division of Clinical Pharmacology

    My research explores how to personalize the dosing of antibiotics and other medications in critically ill patients and in those patients with complex diseases.

  • Laura Ramsey, PhD

    Division of Research in Patient Services, Division of Clinical Pharmacology

    My lab is interested in all aspects of pharmacogenetics, from basic research to implementation in patient care.

About this blog

The Research Horizons blog features news and insights about the latest discoveries and innovations developed by the scientists of Cincinnati Children's. This blog does not provide medical advice, diagnosis, or treatment.